[PDF][PDF] Single-cell sequencing of peripheral mononuclear cells reveals distinct immune response landscapes of COVID-19 and influenza patients
…, L Yu, J Yan, G Diao, F Meng, C Bai, P Mao, Y Yu… - Immunity, 2020 - cell.com
The coronavirus disease 2019 (COVID-19) pandemic poses a current world-wide public health
threat. However, little is known about its hallmarks compared to other infectious diseases. …
threat. However, little is known about its hallmarks compared to other infectious diseases. …
[HTML][HTML] The advanced development of molecular targeted therapy for hepatocellular carcinoma
T Yan, L Yu, N Zhang, C Peng, G Su… - Cancer Biology & …, 2022 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC), one of the most common malignant tumors in China,
severely threatens the life and health of patients. In recent years, precision medicine, clinical …
severely threatens the life and health of patients. In recent years, precision medicine, clinical …
Epidemiological and clinical features of COVID-19 patients with and without pneumonia in Beijing, China
…, L Yu, Z Wang, Z Hong, Z Xiao, Q Xi, D Zhao, P Yu… - Medrxiv, 2020 - medrxiv.org
Background SARS-CoV-2-caused coronavirus disease (COVID-19) is posing a large
casualty. The features of COVID-19 patients with and without pneumonia, SARS-CoV-2 …
casualty. The features of COVID-19 patients with and without pneumonia, SARS-CoV-2 …
[HTML][HTML] Comprehensive analysis of microRNA-regulated protein interaction network reveals the tumor suppressive role of microRNA-149 in human hepatocellular …
Y Zhang, X Guo, L Xiong, L Yu, Z Li, Q Guo, Z Li, B Li… - Molecular cancer, 2014 - Springer
Background Our previous study identified AKT1, AKT2 and AKT3 as unfavorable prognostic
factors for patients with hepatocellular carcinoma (HCC). However, limited data are …
factors for patients with hepatocellular carcinoma (HCC). However, limited data are …
[HTML][HTML] Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patients
…, J Pan, K Hu, M Guan, L Huo, J Shi, L Yu… - Hepatology …, 2023 - Springer
Introduction Combining lenvatinib with a programmed cell death protein-1 (PD-1) inhibitor
has been explored for the treatment of un-resectable hepatocellular carcinoma (uHCC). This …
has been explored for the treatment of un-resectable hepatocellular carcinoma (uHCC). This …
MicroRNA-224 upregulation and AKT activation synergistically predict poor prognosis in patients with hepatocellular carcinoma
L Yu, J Zhang, X Guo, Z Li, P Zhang - Cancer epidemiology, 2014 - Elsevier
Background and aim Previous evidence has shown that microRNA (miR)-224 may function
as an onco-miRNA in hepatocellular carcinoma (HCC) cells by activating AKT signaling. …
as an onco-miRNA in hepatocellular carcinoma (HCC) cells by activating AKT signaling. …
[HTML][HTML] Preclinical investigation of artesunate as a therapeutic agent for hepatocellular carcinoma via impairment of glucosylceramidase-mediated autophagic …
W Chen, Z Ma, L Yu, X Mao, N Ma, X Guo… - … & Molecular Medicine, 2022 - nature.com
Artesunate (ART) has been indicated as a candidate drug for hepatocellular carcinoma (HCC).
Glucosylceramidase (GBA) is required for autophagic degradation. Whether ART …
Glucosylceramidase (GBA) is required for autophagic degradation. Whether ART …
Artesunate Sensitizes human hepatocellular carcinoma to sorafenib via exacerbating AFAP1L2-SRC-FUNDC1 axis-dependent mitophagy
Z Ma, W Chen, Y Liu, L Yu, X Mao, X Guo, F Jiang… - Autophagy, 2024 - Taylor & Francis
Sorafenib is the most widely used first-line drug for the treatment of the advanced hepatocellular
carcinoma (HCC). Unfortunately, sorafenib resistance often limits its therapeutic efficacy…
carcinoma (HCC). Unfortunately, sorafenib resistance often limits its therapeutic efficacy…
[HTML][HTML] FOXO3a Alleviates the Inflammation and Oxidative Stress via Regulating TGF-β and HO-1 in Ankylosing Spondylitis
S Xu, X Zhang, Y Ma, Y Chen, H Xie, L Yu… - Frontiers in …, 2022 - frontiersin.org
This study aimed to investigate whether Forkhead box O3a (FOXO3a) modulates inflammation
and oxidative stress in ankylosing spondylitis (AS). We applied bioinformatics analysis, …
and oxidative stress in ankylosing spondylitis (AS). We applied bioinformatics analysis, …
[HTML][HTML] Identification of GRB2 and GAB1 coexpression as an unfavorable prognostic factor for hepatocellular carcinoma by a combination of expression profile and …
Y Zhang, Z Li, M Yang, D Wang, L Yu, C Guo, X Guo… - PloS one, 2013 - journals.plos.org
Aim To screen novel markers for hepatocellular carcinoma (HCC) by a combination of
expression profile, interaction network analysis and clinical validation. Methods HCC significant …
expression profile, interaction network analysis and clinical validation. Methods HCC significant …